Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study [Meeting Abstract]

dc.authoridELVERDI, TUGRUL/0000-0001-9496-5353
dc.authoridDogu, Mehmet Hilmi/0000-0001-7237-2637
dc.authoridKaynar, Leylagul/0000-0002-2035-9462
dc.authoridYigenoglu, Tugce/0000-0001-9962-8882
dc.authorwosidELVERDI, TUGRUL/D-4366-2019
dc.authorwosidDogu, Mehmet Hilmi/W-2255-2017
dc.authorwosidYigenoglu, Tugce/ABF-6595-2021
dc.authorwosidKaynar, Leylagul/F-6991-2013
dc.contributor.authorOzbalak, Murat
dc.contributor.authorAkay, Olga Meltem
dc.contributor.authorPehlivan, Mustafa
dc.contributor.authorYildiz, Birol
dc.contributor.authorUzay, Ant
dc.contributor.authorYigenoglu, Tugce Nur
dc.contributor.authorElverdi, Tugrul
dc.date.accessioned2023-01-12T20:22:18Z
dc.date.available2023-01-12T20:22:18Z
dc.date.issued2021
dc.departmentN/A/Departmenten_US
dc.description.abstract[No Abstract Available]en_US
dc.identifier.endpageS369en_US
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.startpageS368en_US
dc.identifier.urihttps://hdl.handle.net/11454/79395
dc.identifier.volume21en_US
dc.identifier.wosWOS:000691910500283en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherCig Media Group, Lpen_US
dc.relation.ispartofClinical Lymphoma Myeloma & Leukemiaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectrelapsed and refractoryen_US
dc.subjectHodgkin lymphomaen_US
dc.subjectbrentuximab vedotinen_US
dc.subjectautologous stem cell transplantationen_US
dc.subjectconsolidationen_US
dc.titleBrentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study [Meeting Abstract]en_US
dc.typeConference Objecten_US

Dosyalar